Skip to main content
OpenTrials

Clinical trial condition

Anemia, Hemolytic, Congenital

Explore clinical trials studying Anemia, Hemolytic, Congenital. Study availability and eligibility vary by location and protocol.

1,131 public trials 184 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Hemolytic, Congenital trial results

Recruiting

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

NCT07187973

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emory University Atlanta, Georgia, United States
  • Augusta University Augusta, Georgia, United States
  • Innovative Hematology - Indiana Hemophilia & Thrombosis Center Indianapolis, Indiana, United States
View Trial Details
Recruiting

Natural History of Sickle Cell Disease

NCT00081523

Conditions
Acute Chest Syndrome, Anemia, Anemia, Hemolytic, +15 more
Locations
  • Childrens National Health Center Washington D.C., District of Columbia, United States
  • Suburban Hospital Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

NCT02675959

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • New York Medical College Valhalla, New York, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Recruiting

Cooperative Assessment of Late Effects for SCD Curative Therapies

NCT05153967

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +20 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

NCT06439082

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • University Of Alabama Birmingham, Alabama, United States
  • Ctr for Inherited Blood Disorders Orange, California, United States
  • Childrens National Hospital Washington D.C., District of Columbia, United States
  • University of Florida Jacksonville, Florida, United States
View all 32 locations
View Trial Details

Related conditions